Drug Type Gene therapy |
Synonyms KRIYA 839 |
Target |
Mechanism glucokinase activators(Glucokinase activators), insulin modulators(insulin modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Kriya Therapeutics, Inc.Startup |
Active Organization Kriya Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus | Preclinical | US | Kriya Therapeutics, Inc.Startup | 08 Jan 2024 |